B Cells Are Required to Generate Optimal Anti-Melanoma Immunity in Response to Checkpoint Blockade

Immunotherapies such as checkpoint blockade therapies are known to enhance anti-melanoma CD8(+) T cell immunity, but only a fraction of patients treated with these therapies achieve durable immune response and disease control. It may be that CD8(+) T cells need help from other immune cells to genera...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Shubhra, Roszik, Jason, Saini, Neeraj, Singh, Vipul Kumar, Bavisi, Karishma, Wang, Zhiqiang, Vien, Long T., Yang, Zixi, Kundu, Suprateek, Davis, Richard E., Bover, Laura, Diab, Adi, Neelapu, Sattva S., Overwijk, Willem W., Rai, Kunal, Singh, Manisha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204262/
https://www.ncbi.nlm.nih.gov/pubmed/35720386
http://dx.doi.org/10.3389/fimmu.2022.794684

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204262/
https://www.ncbi.nlm.nih.gov/pubmed/35720386
http://dx.doi.org/10.3389/fimmu.2022.794684

Ejemplares similares